Vaginal Bleeding Associated with Venlafaxine Add-On Therapy: A Case Report.
- Author:
Duk In JON
1
Author Information
1. Department of Psychiatry, Hallym University College of Medicine, Anyang, Korea. cogni@hallym.or.kr
- Publication Type:Case Report
- Keywords:
Venlafaxine;
Vaginal bleeding;
Add-on therapy;
Fluoxetine
- MeSH:
Adult;
Antidepressive Agents;
Drug-Related Side Effects and Adverse Reactions;
Fluoxetine;
Hemorrhage;
Humans;
Hypertension;
Uterine Hemorrhage*;
Venlafaxine Hydrochloride
- From:Korean Journal of Psychopharmacology
2006;17(2):238-240
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Venlafaxine is often considered to be safer than established antidepressants except the risk of hypertension. In terms of vaginal bleeding associated with venlafaxine, only one case has been reported. The author describes a vaginal bleeding occurred in a 38-year-old depressed patient who has been receiving additional venlafaxine during fluoxetine medication. Discontinuation of venlafaxine supported the assumption that the vaginal bleeding was an adverse drug reaction of venlafaxine. Physicians should be alerted to the possibility of bleeding tendency in patients who have taken venlafaxine.
